Regulation of p53 stability and function by the deubiquitinating enzyme USP42

被引:89
作者
Hock, Andreas K. [1 ]
Vigneron, Arnaud M. [1 ]
Carter, Stephanie [1 ]
Ludwig, Robert L. [1 ]
Vousden, Karen H. [1 ]
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
关键词
deubiquitination; MDM2; p53; USP42; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; PATHWAY; MDM2; HAUSP; DESTABILIZATION; TRANSCRIPTION; APOPTOSIS; LIGASE; STRESS;
D O I
10.1038/emboj.2011.419
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumour suppressor protein is a transcription factor that prevents oncogenic progression by activating the expression of apoptosis and cell-cycle arrest genes in stressed cells. The stability of p53 is tightly regulated by ubiquitin-dependent degradation, driven mainly by the ubiquitin ligase MDM2. In this study, we have identified USP42 as a DUB that interacts with and deubiquitinates p53. USP42 forms a direct complex with p53 and controls level of ubiquitination during the early phase of the response to a range of stress signals. Although we do not find a clear role for USP42 in controlling either the basal or fully activated levels of p53, the function of USP42 is required to allow the rapid activation of p53-dependent transcription and a p53-dependent cell-cycle arrest in response to stress. These functions of USP42 are likely to contribute to the repair and recovery of cells from mild or transient damage. The EMBO Journal (2011) 30, 4921-4930. doi:10.1038/emboj.2011.419; Published online 15 November 2011
引用
收藏
页码:4921 / 4930
页数:10
相关论文
共 32 条
[1]   Living with p53, dying of p53 [J].
Aylon, Yael ;
Oren, Moshe .
CELL, 2007, 130 (04) :597-600
[2]   TP53 status and response to chemotherapy in breast cancer [J].
Bertheau, Philippe ;
Espie, Marc ;
Turpin, Elisabeth ;
Lehmann, Jacqueline ;
Plassa, Louis-Francois ;
Varna, Mariana ;
Janin, Anne ;
de The, Hugues .
PATHOBIOLOGY, 2008, 75 (02) :132-139
[3]   MDM2 is a central node in the p53 pathway: 12 years and counting [J].
Bond, GL ;
Hu, WW ;
Levine, AJ .
CURRENT CANCER DRUG TARGETS, 2005, 5 (01) :3-8
[4]   REGULATION OF TRANSCRIPTION FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR BY THE MDM-2 ONCOGENE [J].
CHEN, JD ;
LIN, JY ;
LEVINE, AJ .
MOLECULAR MEDICINE, 1995, 1 (02) :142-152
[5]   HAUSP is required for p53 destabilization [J].
Cummins, JM ;
Vogelstein, B .
CELL CYCLE, 2004, 3 (06) :689-692
[6]   Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53 [J].
Dayal, Saurabh ;
Sparks, Alison ;
Jacob, Jimmy ;
Allende-Vega, Nerea ;
Lane, David P. ;
Saville, Mark K. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (08) :5030-5041
[7]   Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53 [J].
Fang, SY ;
Jensen, JP ;
Ludwig, RL ;
Vousden, KH ;
Weissman, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8945-8951
[8]   Single-nucleotide Polymorphisms in the p53 Signaling Pathway [J].
Grochola, Lukasz F. ;
Zeron-Medina, Jorge ;
Meriaux, Sophie ;
Bond, Gareth L. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (05) :a001032
[9]  
Hainaut P, 2000, ADV CANCER RES, V77, P81
[10]   Coping with stress: multiple ways to activate p53 [J].
Horn, H. F. ;
Vousden, K. H. .
ONCOGENE, 2007, 26 (09) :1306-1316